| Theme |
Therapeutic drugs for osteoporosis |
| Title |
Antiresorption therapies except bisphosphonates -- SERM, anti–RANKL antibody, vitamin D |
| Author |
Michiyo Sugiyama |
Department of Obstetrics and Gynecology, Gifu University Graduate School of Medicine |
| Author |
Eriko Kawashima |
Department of Obstetrics and Gynecology, Gifu University Graduate School of Medicine |
| Author |
Kenichirou Morishige |
Department of Obstetrics and Gynecology, Gifu University Graduate School of Medicine |
| [ Summary ] |
Conventionally, bisphosphonates have been administered to elderly patients and patients at high risk. However, various novel anti-resorption drugs have shown wide usefulness with effects seen in both comparatively young patients with osteopenia and in elderly patients at high fracture risk. Therefore, a thorough understanding of the characteristics of each drug along with individualized treatment planning is required. |